Pear Therapeutics, a developer of prescription digital therapies, has gone public through a merger with Thimble Point Acquisition Corp., a special purpose acquisition company.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}